Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk Reinhardt

Showing results (1-10 of 223) with videos related to

Pageof 23
Sort By:
Cancers|April 3, 2021
Redirecting the Immune Microenvironment in Acute Myeloid LeukemiaStephanie Sendker, Dirk Reinhardt, Naghmeh Niktoreh
Journal of Thoracic Disease|February 1, 2019
Cardio-toxicity in childhood cancer survivors "Cure is not enough"Ulrich Neudorf, Anne Schönecker, Dirk Reinhardt
Journal of Clinical Medicine|February 15, 2022
Pediatric Acute Myeloid Leukemia-Past, Present, and FutureDirk Reinhardt, Evangelia Antoniou, Katharina Waack
Drug Safety|November 28, 2002
Minimising the long-term adverse effects of childhood leukaemia therapyClaudia Langebrake, Dirk Reinhardt, Jörg Ritter
Children (Basel, Switzerland)|June 2, 2021
Far from Health: The Bone Marrow Microenvironment in AML, A Leukemia Supportive ShelterStephanie Sendker, Katharina Waack, Dirk Reinhardt
Medizinische Klinik (Munich, Germany : 1983)|December 14, 2007
[AV Shunt: a rare cause of cardiac decompensation]Nico Fiedler, Dirk Reinhardt, Hans Reiner Figulla
Clinical Chemistry|February 10, 2007
Preanalytical mRNA stabilization of whole bone marrow samplesClaudia Langebrake, Kalle Günther, Jürgen Lauber, et al.
Children (Basel, Switzerland)|February 25, 2023
Is an Exercise Program for Pediatric Cancer Patients in Palliative Care Feasible and Supportive?-A Case SeriesRonja Beller, Gabriele Gauß, Dirk Reinhardt, et al.
British Journal of Clinical Pharmacology|September 13, 2003
Population pharmacokinetics of liposomal daunorubicin in childrenGeorg Hempel, Dirk Reinhardt, Ursula Creutzig, et al.
Pediatric Blood & Cancer|December 22, 2006
Longitudinal evaluation of early and late anthracycline cardiotoxicity in children with AMLUrsula Creutzig, Sylke Diekamp, Martin Zimmermann, et al.
Pageof 23

Showing results (1-10 of 223) with videos related to

Sort By:
Pageof 23
Cancers|April 3, 2021
Redirecting the Immune Microenvironment in Acute Myeloid LeukemiaStephanie Sendker, Dirk Reinhardt, Naghmeh Niktoreh
Journal of Thoracic Disease|February 1, 2019
Cardio-toxicity in childhood cancer survivors "Cure is not enough"Ulrich Neudorf, Anne Schönecker, Dirk Reinhardt
Journal of Clinical Medicine|February 15, 2022
Pediatric Acute Myeloid Leukemia-Past, Present, and FutureDirk Reinhardt, Evangelia Antoniou, Katharina Waack
Drug Safety|November 28, 2002
Minimising the long-term adverse effects of childhood leukaemia therapyClaudia Langebrake, Dirk Reinhardt, Jörg Ritter
Children (Basel, Switzerland)|June 2, 2021
Far from Health: The Bone Marrow Microenvironment in AML, A Leukemia Supportive ShelterStephanie Sendker, Katharina Waack, Dirk Reinhardt
Medizinische Klinik (Munich, Germany : 1983)|December 14, 2007
[AV Shunt: a rare cause of cardiac decompensation]Nico Fiedler, Dirk Reinhardt, Hans Reiner Figulla
Clinical Chemistry|February 10, 2007
Preanalytical mRNA stabilization of whole bone marrow samplesClaudia Langebrake, Kalle Günther, Jürgen Lauber, et al.
Children (Basel, Switzerland)|February 25, 2023
Is an Exercise Program for Pediatric Cancer Patients in Palliative Care Feasible and Supportive?-A Case SeriesRonja Beller, Gabriele Gauß, Dirk Reinhardt, et al.
British Journal of Clinical Pharmacology|September 13, 2003
Population pharmacokinetics of liposomal daunorubicin in childrenGeorg Hempel, Dirk Reinhardt, Ursula Creutzig, et al.
Pediatric Blood & Cancer|December 22, 2006
Longitudinal evaluation of early and late anthracycline cardiotoxicity in children with AMLUrsula Creutzig, Sylke Diekamp, Martin Zimmermann, et al.
Pageof 23